Cloud PR Wire

Nava Health Announces New Precision-Driven Longevity Protocols Following Landmark 2026 Menopause Study

United States, 12th Mar 2026 — New clinical findings released in 2026 are reshaping the conversation around hormone health and aging. As growing research highlights the benefits of Bioidentical Hormone Replacement Therapy (BHRT), Nava Health is announcing the expansion of its precision-driven longevity protocols designed to help men and women restore hormonal balance and improve overall health outcomes.

Historically, hormone therapy has faced skepticism due to earlier studies that evaluated synthetic hormone treatments. However, recent data and improved clinical practices are helping to distinguish bioidentical hormone therapy from older hormone replacement models. These updated insights confirm that properly prescribed and medically monitored BHRT can be a safe and effective option for individuals experiencing hormone imbalances associated with menopause, perimenopause, and andropause.

According to health experts, hormone imbalance can significantly affect daily life. Symptoms such as fatigue, brain fog, sleep disturbances, mood swings, decreased libido, and unexplained weight gain are often linked to hormonal shifts that occur naturally with age. Bioidentical hormone therapy addresses these changes by restoring optimal levels of estrogen, progesterone, and testosterone using plant-derived compounds that are chemically identical to the hormones naturally produced by the human body.

At Nava Health, BHRT is delivered through a comprehensive, data-driven approach that emphasizes early detection and personalized care. The clinic integrates advanced diagnostic testing, clinical evaluation, and continuous monitoring to develop customized hormone optimization plans tailored to each patient’s biology and long-term health goals.

The clinic’s longevity program includes more than 200 laboratory tests conducted annually to assess biomarkers related to hormones, metabolic health, inflammation, and cardiovascular risk. This detailed analysis allows practitioners to identify subtle hormonal imbalances early and design therapies that optimize health at every stage of life.

“Bioidentical hormone therapy is not about masking symptoms—it’s about restoring balance and supporting the body’s natural systems,” said Zachary Dancel, Chief Operating Officer of Nava Health. “The latest clinical evidence reinforces what functional medicine practitioners have observed for years: when hormone therapy is personalized and medically supervised, it can significantly improve quality of life while supporting long-term health and longevity.”

Unlike traditional hormone therapy approaches that rely on a single lab value, Nava Health evaluates multiple biomarkers to create a comprehensive picture of each patient’s health profile. This integrative model allows the medical team to design targeted therapies that address underlying imbalances rather than temporary symptom relief.

Bioidentical hormone therapy may be delivered through a variety of methods depending on individual needs, including hormone injections, topical creams, oral medications, and subdermal hormone pellets. Each delivery method is selected to maintain stable hormone levels while maximizing safety, comfort, and treatment effectiveness.

Beyond symptom management, emerging research suggests that hormone optimization may offer broader health benefits when implemented correctly. Clinical observations indicate improvements in cardiovascular health markers, metabolic function, bone density, cognitive performance, and sleep quality among patients receiving personalized hormone therapy programs.

For women experiencing menopause or perimenopause, BHRT may help alleviate common symptoms such as hot flashes, night sweats, and mood fluctuations. For men, hormone therapy may support energy levels, muscle mass, mental clarity, and sexual health as testosterone levels gradually decline with age.

At the core of Nava Health’s approach is a preventive and longevity-focused philosophy that combines hormone optimization with functional medicine strategies. This includes comprehensive diagnostic testing, individualized treatment planning, continuous progress monitoring, and integrative support programs designed to enhance overall wellness.

The results have been significant. Nava Health reports that more than 60,000 lives have been improved through its programs, with 90 percent client satisfaction and 95 percent of members showing measurable biomarker improvements within three months.

As new clinical evidence continues to validate the safety and effectiveness of bioidentical hormone therapy, experts believe the stigma surrounding hormone treatment will continue to diminish. With advanced diagnostic tools and personalized treatment protocols, hormone optimization is increasingly viewed as a key component of modern preventive medicine and healthy aging.

Individuals interested in learning more about Bioidentical Hormone Replacement Therapy and Nava Health’s hormone optimization programs can visit:
https://navacenter.com/bio-identical-hormone-replacement-therapy/

About Nava Health

Nava Health is a leading functional medicine and longevity clinic dedicated to helping individuals live longer, healthier, and more vibrant lives. The organization specializes in personalized healthcare solutions that address the root causes of health concerns rather than simply treating symptoms. Through advanced diagnostic testing, precision medicine, and integrative therapies, Nava Health provides comprehensive programs that support hormone optimization, regenerative medicine, weight management, IV micronutrient therapy, aesthetics, and preventive health.

Media Contact

Organization: Nava Health

Contact Person: Zachary Dancel

Website: https://navacenter.com/

Email: Send Email

Contact Number: +18667560284

Country:United States

Release id:42558

Disclaimer: This press release is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individuals should consult a qualified healthcare professional before making decisions related to hormone therapy or any medical treatment. Results and outcomes may vary based on individual health conditions.

The post Nava Health Announces New Precision-Driven Longevity Protocols Following Landmark 2026 Menopause Study appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Infobeat Today journalist was involved in the writing and production of this article.